Editas Medicine (EDIT) FCF Margin Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 43,511.00 |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.06 Mn |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 353,024.00 |
| Dec 31, 2024 | -10,624.00 |
| Sep 30, 2024 | -9.03 Mn |
| Jun 30, 2024 | -1.05 Mn |
| Mar 31, 2024 | -417,709.00 |
| Dec 31, 2023 | 62,356.00 |
| Sep 30, 2023 | 12.16 Mn |
| Jun 30, 2023 | -72,296.00 |
| Mar 31, 2023 | 37,846.00 |
| Dec 31, 2022 | -37,776.00 |
| Sep 30, 2022 | -12.17 Mn |
| Jun 30, 2022 | 997,990.00 |
| Mar 31, 2022 | 240.00 |
| Dec 31, 2021 | 7,038.00 |
| Sep 30, 2021 | -56,806.00 |
| Jun 30, 2021 | -1.02 Mn |
| Mar 31, 2021 | 22,004.00 |
| Dec 31, 2020 | -71,342.00 |
| Sep 30, 2020 | 73,017.00 |
| Jun 30, 2020 | 79,221.00 |
| Mar 31, 2020 | 43,633.00 |
| Dec 31, 2019 | 29,899.00 |
| Sep 30, 2019 | -73,803.00 |
| Jun 30, 2019 | -86,613.00 |
| Mar 31, 2019 | -84,377.00 |
| Sep 30, 2018 | -29,543.00 |
| Jun 30, 2018 | -160,614.00 |
| Mar 31, 2018 | -1.07 Mn |
| Sep 30, 2017 | 179,905.00 |
| Jun 30, 2017 | 171,463.00 |
| Mar 31, 2017 | 1.14 Mn |
| Dec 31, 2016 | -82,311.00 |
| Sep 30, 2016 | 23,238.00 |
| Jun 30, 2016 | -1.21 Mn |